
Sign up to save your podcasts
Or
Ignacio Duran joins the show to discuss the landscape of established ADCs in urothelial cancer and challenges of drug development in this setting.
4.9
5555 ratings
Ignacio Duran joins the show to discuss the landscape of established ADCs in urothelial cancer and challenges of drug development in this setting.
135 Listeners
14 Listeners
319 Listeners
503 Listeners
693 Listeners
59 Listeners
2,422 Listeners
3,327 Listeners
8,025 Listeners
196 Listeners
519 Listeners
2 Listeners
30 Listeners
181 Listeners
2 Listeners